Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24


Rosacea: Epidemiology, pathogenesis, and treatment.

Rainer BM, Kang S, Chien AL.

Dermatoendocrinol. 2017 Oct 4;9(1):e1361574. doi: 10.1080/19381980.2017.1361574. eCollection 2017. Review.


An observational descriptive survey of rosacea in the Chinese population: clinical features based on the affected locations.

Xie HF, Huang YX, He L, Yang S, Deng YX, Jian D, Shi W, Li J.

PeerJ. 2017 Jul 7;5:e3527. doi: 10.7717/peerj.3527. eCollection 2017.


Disseminated extrafacial rosacea with papulonecrotic lesions.

Demitsu T, Tsukahara R, Umemoto N, Nakamura S, Nagashima K, Yamada T, Kakurai M, Tanaka Y, Kakehashi A, Miyata T.

J Dermatol Case Rep. 2016 Dec 31;10(4):68-72. doi: 10.3315/jdcr.2016.1236. eCollection 2016 Dec 31.


Rosacea Subtypes Visually and Optically Distinct When Viewed with Parallel-Polarized Imaging Technique.

Kwon IH, Choi JE, Seo SH, Kye YC, Ahn HH.

Ann Dermatol. 2017 Apr;29(2):167-172. doi: 10.5021/ad.2017.29.2.167. Epub 2017 Mar 24.


Is optical coherence tomography an effective device for evaluation of tear film meniscus in patients with acne rosacea?

Eroglu FC, Karalezli A, Dursun R.

Eye (Lond). 2016 Apr;30(4):545-52. doi: 10.1038/eye.2015.277. Epub 2016 Jan 15.


The role of brimonidine tartrate gel in the treatment of rosacea.

Jackson JM, Knuckles M, Minni JP, Johnson SM, Belasco KT.

Clin Cosmet Investig Dermatol. 2015 Oct 23;8:529-38. doi: 10.2147/CCID.S58920. eCollection 2015. Review.


Brimonidine gel 0.33% rapidly improves patient-reported outcomes by controlling facial erythema of rosacea: a randomized, double-blind, vehicle-controlled study.

Layton AM, Schaller M, Homey B, Hofmann MA, Bewley AP, Lehmann P, Nohlgård C, Sarwer DB, Kerrouche N, Ma YM.

J Eur Acad Dermatol Venereol. 2015 Dec;29(12):2405-10. doi: 10.1111/jdv.13305. Epub 2015 Sep 28.


Randomised controlled trial of topical kanuka honey for the treatment of rosacea.

Braithwaite I, Hunt A, Riley J, Fingleton J, Kocks J, Corin A, Helm C, Sheahan D, Tofield C, Montgomery B, Holliday M, Weatherall M, Beasley R.

BMJ Open. 2015 Jun 24;5(6):e007651. doi: 10.1136/bmjopen-2015-007651.


Treatment of ocular rosacea: comparative study of topical cyclosporine and oral doxycycline.

Arman A, Demirseren DD, Takmaz T.

Int J Ophthalmol. 2015 Jun 18;8(3):544-9. doi: 10.3980/j.issn.2222-3959.2015.03.19. eCollection 2015.


Perceptions on the Psychological Impact of Facial Erythema Associated with Rosacea: Results of International Survey.

Dirschka T, Micali G, Papadopoulos L, Tan J, Layton A, Moore S.

Dermatol Ther (Heidelb). 2015 Jun;5(2):117-27. doi: 10.1007/s13555-015-0077-2. Epub 2015 May 29.


Combination surgical excision and fractional carbon dioxide laser for treatment of rhinophyma.

Kassir R, Gilbreath J, Sajjadian A.

World J Plast Surg. 2012 Jan;1(1):36-40.


The efficacy of intense pulsed light for treating erythematotelangiectatic rosacea is related to severity and age.

Lim HS, Lee SC, Won YH, Lee JB.

Ann Dermatol. 2014 Aug;26(4):491-5. doi: 10.5021/ad.2014.26.4.491. Epub 2014 Jul 31.


Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancer.

Maitland ML, Levine MR, Lacouture ME, Wroblewski KE, Chung CH, Gordon IO, Szeto L, Ratko G, Soltani K, Kozloff MF, Hoffman PC, Salgia R, Carbone DP, Karrison TG, Vokes EE.

BMC Cancer. 2014 Jan 4;14:5. doi: 10.1186/1471-2407-14-5.


Effects of a facial cream containing the minor alkaloid anatabine on improving the appearance of the skin in mild to moderate rosacea: an open-label case series study.

Lanier RK, Cohen AE, Weinkle SH.

Case Rep Dermatol. 2013 Nov 23;5(3):347-56. doi: 10.1159/000357019. eCollection 2013.


Clinical, cellular, and molecular aspects in the pathophysiology of rosacea.

Steinhoff M, Buddenkotte J, Aubert J, Sulk M, Novak P, Schwab VD, Mess C, Cevikbas F, Rivier M, Carlavan I, Déret S, Rosignoli C, Metze D, Luger TA, Voegel JJ.

J Investig Dermatol Symp Proc. 2011 Dec;15(1):2-11. doi: 10.1038/jidsymp.2011.7. Review.


Once-daily topical brimonidine tartrate gel 0·5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies.

Fowler J, Jarratt M, Moore A, Meadows K, Pollack A, Steinhoff M, Liu Y, Leoni M; Brimonidine Phase II Study Group.

Br J Dermatol. 2012 Mar;166(3):633-41. doi: 10.1111/j.1365-2133.2011.10716.x.


Neurogenic rosacea: a distinct clinical subtype requiring a modified approach to treatment.

Scharschmidt TC, Yost JM, Truong SV, Steinhoff M, Wang KC, Berger TG.

Arch Dermatol. 2011 Jan;147(1):123-6. doi: 10.1001/archdermatol.2010.413. No abstract available.

Supplemental Content

Support Center